Compare TTK HEALTHCARE with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ALEMBIC PHARMA TTK HEALTHCARE/
ALEMBIC PHARMA
 
P/E (TTM) x 18.8 15.6 120.2% View Chart
P/BV x 1.5 3.6 41.8% View Chart
Dividend Yield % 1.0 1.1 96.8%  

Financials

 TTK HEALTHCARE   ALEMBIC PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ALEMBIC PHARMA
Mar-19
TTK HEALTHCARE/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,215664 183.0%   
Low Rs610412 147.9%   
Sales per share (Unadj.) Rs444.4208.7 212.9%  
Earnings per share (Unadj.) Rs17.231.0 55.6%  
Cash flow per share (Unadj.) Rs27.637.1 74.5%  
Dividends per share (Unadj.) Rs5.005.50 90.9%  
Dividend yield (eoy) %0.51.0 53.6%  
Book value per share (Unadj.) Rs177.9144.2 123.4%  
Shares outstanding (eoy) m14.13188.52 7.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.6 79.6%   
Avg P/E ratio x52.917.4 304.7%  
P/CF ratio (eoy) x33.014.5 227.7%  
Price / Book Value ratio x5.13.7 137.4%  
Dividend payout %29.017.7 163.4%   
Avg Mkt Cap Rs m12,894101,461 12.7%   
No. of employees `0002.3NA-   
Total wages/salary Rs m1,3077,467 17.5%   
Avg. sales/employee Rs Th2,715.7NM-  
Avg. wages/employee Rs Th565.3NM-  
Avg. net profit/employee Rs Th105.4NM-  
INCOME DATA
Net Sales Rs m6,27939,347 16.0%  
Other income Rs m7894 82.6%   
Total revenues Rs m6,35639,441 16.1%   
Gross profit Rs m4968,736 5.7%  
Depreciation Rs m1471,152 12.7%   
Interest Rs m34184 18.4%   
Profit before tax Rs m3937,493 5.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1491,568 9.5%   
Profit after tax Rs m2445,844 4.2%  
Gross profit margin %7.922.2 35.6%  
Effective tax rate %37.920.9 181.3%   
Net profit margin %3.914.9 26.1%  
BALANCE SHEET DATA
Current assets Rs m2,71719,577 13.9%   
Current liabilities Rs m1,57114,896 10.5%   
Net working cap to sales %18.311.9 153.5%  
Current ratio x1.71.3 131.6%  
Inventory Days Days3290 35.8%  
Debtors Days Days4745 102.9%  
Net fixed assets Rs m99127,097 3.7%   
Share capital Rs m141377 37.5%   
"Free" reserves Rs m2,37326,811 8.9%   
Net worth Rs m2,51427,188 9.2%   
Long term debt Rs m34,993 0.1%   
Total assets Rs m4,15847,778 8.7%  
Interest coverage x12.641.7 30.3%   
Debt to equity ratio x00.2 0.7%  
Sales to assets ratio x1.50.8 183.4%   
Return on assets %6.712.6 52.9%  
Return on equity %9.721.5 45.1%  
Return on capital %16.923.6 71.8%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22519,453 1.2%   
Fx outflow Rs m716,065 1.2%   
Net fx Rs m15413,388 1.2%   
CASH FLOW
From Operations Rs m1738,120 2.1%  
From Investments Rs m97-7,556 -1.3%  
From Financial Activity Rs m-307590 -52.0%  
Net Cashflow Rs m-381,153 -3.3%  

Share Holding

Indian Promoters % 65.4 74.1 88.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 2.9 127.6%  
FIIs % 5.2 9.1 57.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 13.9 185.6%  
Shareholders   12,723 49,328 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ASTRAZENECA PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS